Antitumor activity of the oral EGFR/HER2 inhibitor TAK-788 in NSCLC with EGFR exon 20 insertions Meeting Abstract
| Authors: | Riely, G.; Neal, J.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D.; Tsao, A.; Patel, J.; Gadgeel, S.; Bazhenova, L.; Zhu, V.; West, H.; Vincent, S.; Zhu, J.; Jin, S.; Zhang, S.; Li, S.; Janne, P. |
| Abstract Title: | Antitumor activity of the oral EGFR/HER2 inhibitor TAK-788 in NSCLC with EGFR exon 20 insertions |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | egfr exon 20 mutation; egfr tyrosine kinase inhibitor |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S412 |
| End Page: | S413 |
| Language: | English |
| ACCESSION: | WOS:000492162202171 |
| DOI: | 10.1016/j.jtho.2019.08.842 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.01-127 -- Source: Wos |
